Touted among the most significant medical breakthroughs of this century, blockbuster weight-loss drugs like Ozempic, Wegovy, Mounjaro and Zepbound have captured the zeitgeist
Similarly, immunostaining is fraught with poorly validated and non-specific reagents, and does not allow GPCRs to be dynamically followed in time and space within the same cell(s) 7
Systematic reviews and meta-analyses suggest modest benefits for glycaemic control and lipid profiles in people with type 2 diabetes or metabolic syndrome, but the overall quality of evidence is considered moderate at best
This group creates the largest care pathway because chronic weight management needs repeated clinical review
How Intelligencia supports teams navigating the oral GLP-1 shift We help clinical, portfolio, and BD leaders separate trend from overreach in a market moving at unprecedented speed: Clinical development teams use our benchmarks to compare phase progression, endpoint choices, and development velocity across oral vs injectable GLP-1 programshelping set realistic design and differentiation expectations
Esmaeili N, Gell L, Taranto-Montemurro L, et al
